华尔街称买入Strategy同时获得报酬为其比特币狂欢提供资金

Wall Street remains deeply bullish on Strategy, even as many of the same banks benefit from the stock sales, helping fund its Bitcoin buying spree. That overlap does not prove misconduct, but it does raise a harder question about whether the market’s loudest optimism is being reinforced by the fees attached to it. Strategy is one of the most aggressively promoted stocks on Wall Street, with a consensus “Strong Buy” rating and an average analyst price target that implies a 155% upside from recent prices. That's nearly double the implied upside for any other large-cap name in America. It's also, by a wide margin, the single largest issuer of new stock on any US exchange, having raised an estimated $50 billion in roughly 18 months and paid around $274 million in fees along the way. But the companies setting and publishing those bullish targets, and the companies profiting from that issuance pipeline overlap so much that it threatens to turn into a very serious conflict of interest. The question we have to ask isn't whether anyone is breaking the law, because nobody is, at least for now. It's whether the incentive structure around Strategy has become so tightly wound that Wall Street's enthusiasm and Wall Street's compensation have merged into a single, very bullish, but unjustified emotion. Strategy's analyst ecosystem and who populates it The vast majority of analysts rate Strategy a buy. Bernstein maintains an Outperform with a target that previously sat at $600. TD Cowen carries a Buy at $440. Cantor Fitzgerald rates it Overweight. B. Riley Securities initiated coverage with a Buy in March 2026. The high target on the street, $705, belongs to Benchmark. Only Wells Fargo has issued a conspicuously bearish call, setting a target of just $54. What makes this coverage unusual is the context behind it. Strategy doesn't generate meaningful operating earnings from its legacy software business, which pulls in roughly $120 million per quarter. The real driver of the stock, a